You are here: Industry Insights > Pfizer

News List

Sanofi to produce 100 million Pfizer/BioNTech vaccine doses: CEO expresspharma
January 27, 2021
Sanofi will produce more than 100 million doses of the COVID-19 vaccine developed by its competitors Pfizer and BioNTech by the end of the year, said Paul Hudson, CEO of Sanofi in an interview with Le Figaro newspaper.
Australia approves Pfizer-BioNTech’s Covid-19 vaccine pharmaceutical-technology
January 26, 2021
Australia’s Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer-BioNTech Covid-19 vaccine for use in people aged 16 years and above.
COVAX announces new agreement, plans for first deliveries worldpharmanews
January 25, 2021
COVAX announced the signing of an advance purchase agreement with Pfizer for up to 40 million doses of the Pfizer-BioNTech vaccine candidate, which has already received WHO emergency use listing.
European Commission Approves BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma prnasia
January 25, 2021
Merck and Pfizer Inc. today announced that the European Commission (EC) has approved BAVENCIO® (avelumab) as monotherapy for the first-line maintenance treatment of adult patients with locally advanced or metastatic urothelial carcinoma (UC) who are ...
BioPharma Companies Announce Formation of Accumulus Synergy americanpharmaceuticalreview
January 25, 2021
Ten biopharmaceutical companies announced the formation of a new non-profit corporation, Accumulus Synergy, Inc., which is intended to support interactions between industry and health authorities worldwide to enable real-time collaboration and data ...
Pfizer, BioNTech announce agreement with COVAX for advance purchase of COVID-19 vaccine expresspharma
January 25, 2021
Pfizer and BioNTech announced an advance purchase agreement with COVAX for up to 40 million doses of the Pfizer-BioNTech COVID-19 vaccine. The doses will be delivered throughout 2021.
Italy to take legal action against Pfizer, AstraZeneca over COVID-19 vaccine delays expresspharma
January 25, 2021
The aim was to get the companies to meet the vaccine volumes they had promised and not to seek compensation, said Foreign Minister Luigi Di Maio.
Aviva Pharmacy Provides Initial Doses of COVID-19 Vaccine prnewswire
January 22, 2021
Aviva Pharmacy, an independent pharmacy located in Long Beach, CA has announced that it has obtained supplies of both the Moderna and Pfizer COVID-19 vaccines and has begun administering vaccinations to health care providers and those 65 years of age ...
Pfizer, BioNTech Study Shows COVID-19 Vaccine Elicits Antibodies that Neutralize New U.K. Strain americanpharmaceuticalreview
January 22, 2021
Pfizer and BioNTech announced results from an in vitro study that provides additional data on the capability of sera from individuals immunized with the Pfizer-BioNTech COVID-19 vaccine BNT162b2 to neutralize the SARS-CoV-2 U.K. strain, also known ...
Japan has pre-ordered COVID-19 vaccine doses for more than four times its population, says report europeanpharmaceuticalreview
January 20, 2021
Japan has procurement deals with half of the companies leading the COVID-19 vaccine development race, according to GlobalData.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page